Renaissance Technologies - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 1 filers reported holding HOMOLOGY MEDICINES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$211
-20.4%
180,000
-39.8%
0.00%
Q2 2023$265
-16.7%
299,100
-3.3%
0.00%
Q1 2023$318
-24.3%
309,217
-7.2%
0.00%
-100.0%
Q4 2022$420
-99.9%
333,153
-12.1%
0.00%0.0%
Q3 2022$610,000
+24.5%
379,100
+52.4%
0.00%0.0%
Q2 2022$490,000
-31.1%
248,800
+6.3%
0.00%0.0%
Q1 2022$711,000
+33.9%
234,000
+60.3%
0.00%0.0%
Q4 2021$531,000
-61.2%
145,993
+61.9%
0.00%0.0%
Q2 2020$1,370,000
+63.9%
90,200
+67.7%
0.00%0.0%
Q1 2020$836,00053,7860.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q4 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$16,511,0003.10%
Vida Ventures Advisors, LLC 770,845$2,806,0001.05%
Vivo Capital, LLC 853,143$3,105,0000.19%
AAF Wealth Management, LLC 47,501$173,0000.12%
OUP Management Co., LLC 64,000$233,0000.10%
GSA CAPITAL PARTNERS LLP 195,596$712,0000.09%
Temasek Holdings (Private) Ltd 5,650,996$20,570,0000.07%
Bellevue Group AG 1,737,122$6,323,0000.06%
XTX Topco Ltd 26,212$95,0000.05%
Virtus ETF Advisers LLC 37,588$137,0000.05%
View complete list of HOMOLOGY MEDICINES INC shareholders